Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Xyzal approved in Europe for persistent allergic rhinitis

Dec. 29, 2004

Animal results point to ATL-1102's potential in asthma

Dec. 27, 2004

Additional phase II trial for INS-37217 Respiratory in cystic fibrosis

Dec. 27, 2004

Ono discloses chemokine receptor ligands

Dec. 22, 2004

Nasonex approved in U.S. for nasal polyps

Dec. 20, 2004

5-HT2A/2C agonist improves upper airway stability in rats

Dec. 20, 2004

Two new series of muscarinic receptor antagonists designed at Ranbaxy

Dec. 17, 2004

Novel series of PDE4 inhibitors for inflammatory conditions described in patent literature

Dec. 16, 2004

Theravance describes dual beta2-adrenoceptor agonists/muscarinic receptor antagonists

Dec. 16, 2004

Discovery and Esteve restructure strategic alliance

Dec. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...